Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Clinical trial NCT07287917 · RECRUITING

Trial details

NCT number: NCT07287917
Sponsor: Aminex Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin Cancer)HER2-low Hormone Receptor Positive Breast Cancer

Start date: 2026-01-26
Primary completion: 2028-02-28
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.